Literature DB >> 8831547

Early results of laparoscopic surgery for colorectal cancer. Retrospective analysis of 372 patients treated by Clinical Outcomes of Surgical Therapy (COST) Study Group.

J W Fleshman, H Nelson, W R Peters, H C Kim, S Larach, R R Boorse, W Ambroze, P Leggett, R Bleday, S Stryker, B Christenson, S Wexner, A Senagore, D Rattner, J Sutton, A P Fine.   

Abstract

UNLABELLED: This study was undertaken to determine the early experience of the embers of the COST Study Group with colorectal cancer treated by laparoscopic approaches.
METHOD: A retrospective review was performed of all patients with colorectal cancer treated with laparoscopy by the COST Study Group before August 1994. Tumor site, stage, differentiation, procedure completion, presence of recurrence (local, distant, trocar site), and cause of death were analyzed.
RESULTS: A total of 372 patients with adenocarcinoma of the colon and rectum were treated by laparoscopic approach between October 1991 and August 1994 (170 men and 192 women): right colectomy, 170; sigmoid colectomy, 55; low anterior resection, 56; abdominoperineal resection, 44; left colectomy, 22; colostomy, 8; total colectomy, 6; transverse colectomy, 7; exploration, 2. Conversion to an open procedure was required in 15.6 percent of cases. Operative mortality was 2 percent. Tumor characteristics were as follows: TNM state: I, 40 percent; II, 25 percent; III, 18 percent; IV, 17 percent; Differentiation: well-moderate, 88 percent; poor, 12 percent; carcinomatosis, 5 percent. Local (3.6 percent) and distant implantation occurred in four patients (1.1 percent). Only one of these patients died a cancer-related death (Stage III at 36 months). Cancer-related death rates increased with increasing stage of tumor: I, -4 percent; II, 17 percent; III, 31 percent; IV, 70 percent.
CONCLUSION: A laparoscopic approach to colorectal cancer results in early outcome after treatment that is comparable with conventional therapy for colorectal cancer. A randomized trial is needed to compare long-term outcomes of open and laparoscopic approaches with colorectal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8831547     DOI: 10.1007/bf02053806

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  65 in total

1.  The impact of laparoscopy on cancer management.

Authors:  F L Greene
Journal:  Surg Endosc       Date:  2000-03       Impact factor: 4.584

2.  Current status of laparoscopic colectomy--is it experimental?

Authors:  H Nelson
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

3.  Converted laparoscopic colorectal surgery.

Authors:  P Gervaz; A Pikarsky; M Utech; M Secic; J Efron; B Belin; A Jain; S Wexner
Journal:  Surg Endosc       Date:  2001-05-11       Impact factor: 4.584

4.  Raising the bar. Laparoscopic resection of colorectal cancer.

Authors:  T M Young-Fadok
Journal:  Surg Endosc       Date:  2001-08-08       Impact factor: 4.584

Review 5.  Surgical management of colon cancer.

Authors:  Patrick H D Colquhoun; Steven D Wexner
Journal:  Curr Gastroenterol Rep       Date:  2002-10

6.  SAGES Appropriateness Conference: a summary.

Authors:  R E Glasgow; A Fingerhut; J Hunter
Journal:  Surg Endosc       Date:  2003-09-29       Impact factor: 4.584

7.  Should carcinoma of the colon be treated laparoscopically? Point.

Authors:  R L Whelan
Journal:  Surg Endosc       Date:  2004-05       Impact factor: 4.584

Review 8.  Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.

Authors:  Tracilyn Hall; Susanna I Lee; David M Boruta; Annekathryn Goodman
Journal:  Oncologist       Date:  2015-09-17

9.  COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer.

Authors:  E J Hazebroek
Journal:  Surg Endosc       Date:  2002-03-18       Impact factor: 4.584

10.  Could laparoscopic colon and rectal surgery become the standard of care? A review and experience with 750 procedures.

Authors:  Christopher M Schlachta; Joseph Mamazza; Roger Gregoire; Stephen E Burpee; Eric C Poulin
Journal:  Can J Surg       Date:  2003-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.